These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16495863)

  • 1. [Erythema dyschromicum perstans].
    Sebbag N; Lacour JP
    Ann Dermatol Venereol; 2006 Jan; 133(1):79-82. PubMed ID: 16495863
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythema dyschromicum perstans: a case report and review.
    Osswald SS; Proffer LH; Sartori CR
    Cutis; 2001 Jul; 68(1):25-8. PubMed ID: 11480143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythema cinitiensis perstans].
    Sittart JA; Tayah M
    Med Cutan Ibero Lat Am; 1980; 8(1-3):11-4. PubMed ID: 7022047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema dyschromicum perstans in phototype II women: three unusual clinical cases studied with electron microscopy.
    Persechino S; Caperchi C; Cortesi G; Persechino F; Raffa S; Pulcini F; Tammaro A; Torrisi MR
    Eur J Dermatol; 2011; 21(2):261-2. PubMed ID: 21382781
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythema dyschromicum perstans: response to dapsone therapy.
    Bahadir S; Cobanoglu U; Cimsit G; Yayli S; Alpay K
    Int J Dermatol; 2004 Mar; 43(3):220-2. PubMed ID: 15009398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythema dyschromicum perstans].
    Möller-Vietheer M; Goos M
    Hautarzt; 1977 Oct; 28(10):539-41. PubMed ID: 340421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema dyschromicum perstans: response to dapsone therapy.
    Kontochristopoulos G; Stavropoulos P; Panteleos D; Aroni K
    Int J Dermatol; 1998 Oct; 37(10):796-8. PubMed ID: 9802694
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultrastructural pathology of erythema dyschromicum perstans.
    Soter NA; Wand C; Freeman RG
    J Invest Dermatol; 1969 Feb; 52(2):155-62. PubMed ID: 5774894
    [No Abstract]   [Full Text] [Related]  

  • 9. Asymptomatic progressive hyperpigmentation in a 16-year-old girl. Erythema dyschromicum perstans.
    Nelson BR; Ramsey ML; Bruce S; Tschen JA; Knox JM
    Arch Dermatol; 1988 May; 124(5):769, 772. PubMed ID: 3365000
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythema dyschromicum perstans.
    Novick NL; Phelps R
    Int J Dermatol; 1985 Dec; 24(10):630-3. PubMed ID: 3910593
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneously active lesions of vitiligo and erythema dyschromicum perstans.
    Henderson CD; Tschen JA; Schaefer DG
    Arch Dermatol; 1988 Aug; 124(8):1258-60. PubMed ID: 3401033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Macular idiopathic pigmentation (erythema dyschromicum perstans)].
    Karalitskiĭ EM; Khmelevskiĭ AD
    Vestn Dermatol Venerol; 1984 Feb; (2):49-51. PubMed ID: 6720074
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy.
    Baranda L; Torres-Alvarez B; Cortes-Franco R; Moncada B; Portales-Perez DP; Gonzalez-Amaro R
    Arch Dermatol; 1997 Mar; 133(3):325-9. PubMed ID: 9080892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema dyschromicum perstans: the continuing enigma of Cinderella or ashy dermatosis.
    Schwartz RA
    Int J Dermatol; 2004 Mar; 43(3):230-2. PubMed ID: 15009400
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythema dyschromicum perstans. Immunopathologic studies.
    Miyagawa S; Komatsu M; Okuchi T; Shirai T; Sakamoto K
    J Am Acad Dermatol; 1989 May; 20(5 Pt 2):882-6. PubMed ID: 2785541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema dyschromicum perstans in a Caucasian pediatric patient.
    Tisack AM; Huggins RH; Lim HW
    J Drugs Dermatol; 2013 Jul; 12(7):819-20. PubMed ID: 23884499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema dyschromicum perstans with a Wagyu beef-like appearance on dermoscopy.
    Tomii K; Fujimoto A; Yokoyama R; Kabata Y; Fujita S; Hayashi R; Abe R
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):e141-e142. PubMed ID: 31746505
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythema dyschromicum perstans. A follow-up study from northern Finand.
    Palatsi R
    Dermatologica; 1977; 155(1):40-4. PubMed ID: 913745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema dyschromicum perstans and hepatitis C virus infection.
    Kontochristopoulos GJ; Aroni K; Anagnostopoulos G; Nakopoulou L; Tassopoulos NC
    Int J Dermatol; 2001 May; 40(5):346-8. PubMed ID: 11555000
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ashy dermatosis (erithema dyschromicum perstans): prospective study of 23 patients].
    Navarro Jiménez BR; Sánchez Navarro LM
    Med Cutan Ibero Lat Am; 1988; 16(5):407-12. PubMed ID: 3070197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.